A re-evaluation of squamous cell carcinoma antigen (SCC) as a serum marker for non-small cell lung cancer

Medical Oncology

Volumn 25, Issue 2, 2008, Pages 187-189

  Kagohashi, Katsunori ^a   Satoh, Hiroaki ^a   Ishikawa, Hiroichi ^a   Ohtsuka, Morio ^a   Sekizawa, Kiyohisa ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

CYFRA; Diagnosis; Non small cell lung cancer; SCC; Tumor marker

Indexed keywords

CYTOKERATIN 19 FRAGMENT; SQUAMOUS CELL CARCINOMA ANTIGEN; ANTIGEN CYFRA21.1; KERATIN; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA RELATED ANTIGEN; SQUAMOUS CELL CARCINOMA-RELATED ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CONTROLLED STUDY; HUMAN; JAPAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; BLOOD; LUNG TUMOR;

ANTIGENS, NEOPLASM; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; KERATINS; LUNG NEOPLASMS; SERPINS; TUMOR MARKERS, BIOLOGICAL;

EID: 48049105367     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-007-9021-3     Document Type: Article

References (15)

1. GF Buccheri 1987 Tumor markers in bronchogenic carcinoma: superiority of tissue polypeptide antigen to carcinoembryonic antigen and carbohydrate antigenic determinant 19-9 Cancer 60 42 50
2. C Lombardi GF Tassi G Pizzocolo F. Donato 1990 Clinical significance of a multiple biomarker assay in patients with lung cancer: a study with logistic regression analysis Chest 97 639 44
3. H Satoh 2002 Cut-off levels of NSE to differentiate SCLC from NSCLC Oncol Rep 9 581 83
4. H Kato F Miyauchi H Morioka T Fujino T. Torigoe 1979 Tumor antigen of human cervical squamous cell carcinoma-circulation levels with disease progress Cancer 43 585 90
5. H Kato H Morioka H Tsutsui S Aramaki T. Torigoe 1982 Value of tumor antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer Cancer 50 1294 96
6. N Mino A Iio K. Hamamoto 1988 Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs Cancer 62 730 34
7. F Palermo A Carniato A Fede F Boccaletto C. Marchiori 1990 Serum SCC-Ag in head and neck squamous cell carcinoma Int J Biol Markers. 5 118 20
8. J De Sanchez Cos F Masa JL de la Cruz C Disdier C. Vergara 1994 Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer Chest 105 773 76
9. J Niklinski M Furman J Laudanski M. Kozlowski 1992 Evaluation of squamous cell carcinoma antigen (SCC-Ag) in the diagnosis and follow-up of patients with non-small cell lung carcinoma Neoplasma 39 279 82
10. D Moro D Villemain PJ Vuillez AC Delord C. Brambilla 1995 CEA, CYFRA21-1 and SCC in non-small cell lung cancer Lung Cancer 13 169 76
11. JL Pujol 1993 Serum fragment of cytokeratin subunit 19 measured by CYFRA 21-1: immunoradiometric assay as a marker of lung cancer Cancer Res 53 61 66
12. H Satoh S Ishikawa H Kamma M Ohtsuka S. Hasegawa 1998 Preoperative CYFRA 21-1 levels in patients with lung cancer: correlation with mediastinal lymph node involvement Eur J Cancer 34 1469 70
13. K Kashiwabara H Nakamura T. Esaki 2000 Prognosis in bronchogenic squamous cell carcinoma groups divided according to serum squamous cell carcinoma-related antigen and cytokeratin 19 fragment levels Clin Chim Acta 294 105 13
14. CF. Mountain 1997 Revisions in the International System for Staging Lung Cancer Chest 111 1710 17
15. P Petignat F Joris R. Obrist 2000 How CA125 is used in routine clinical practice Eur J Cancer 36 1933 37